UFP Technologies, Inc. (UFPT)
NASDAQ: UFPT · IEX Real-Time Price · USD
312.80
-11.28 (-3.48%)
At close: Jul 19, 2024, 4:00 PM
312.84
+0.04 (0.01%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
UFP Technologies Market Cap
UFP Technologies has a market cap or net worth of $2.40 billion as of July 22, 2024. Its market cap has increased by 67.15% in one year.
Market Cap
2.40B
Enterprise Value
2.44B
1-Year Change
67.15%
Ranking
Category
Stock Price
$312.80
Market Cap Chart
Since December 1, 1998, UFP Technologies's market cap has increased from $15.40M to $2.40B, an increase of 15,480.06%. That is a compound annual growth rate of 21.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 2.40B | 82.57% |
Dec 29, 2023 | 1.31B | 47.10% |
Dec 30, 2022 | 893.40M | 68.82% |
Dec 31, 2021 | 529.20M | 51.50% |
Dec 31, 2020 | 349.30M | -5.34% |
Dec 31, 2019 | 369.00M | 66.59% |
Dec 31, 2018 | 221.50M | 9.65% |
Dec 29, 2017 | 202.00M | 9.78% |
Dec 30, 2016 | 184.00M | 8.24% |
Dec 31, 2015 | 170.00M | -2.02% |
Dec 31, 2014 | 173.50M | -0.12% |
Dec 31, 2013 | 173.70M | 44.03% |
Dec 31, 2012 | 120.60M | 25.10% |
Dec 30, 2011 | 96.40M | 27.18% |
Dec 31, 2010 | 75.80M | 96.88% |
Dec 31, 2009 | 38.50M | 29.19% |
Dec 31, 2008 | 29.80M | -24.56% |
Dec 31, 2007 | 39.50M | 36.68% |
Dec 29, 2006 | 28.90M | 153.51% |
Dec 30, 2005 | 11.40M | -35.23% |
Dec 31, 2004 | 17.60M | 100.00% |
Dec 31, 2003 | 8.80M | 95.56% |
Dec 31, 2002 | 4.50M | - |
Dec 31, 2001 | 4.50M | -39.19% |
Dec 29, 2000 | 7.40M | -44.78% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ardent Health Partners | 2.48B |
Integra LifeSciences Holdings | 2.47B |
Vericel | 2.44B |
Celldex Therapeutics | 2.42B |
Intellia Therapeutics | 2.42B |
Myriad Genetics | 2.35B |
CG Oncology | 2.35B |
Fortrea Holdings | 2.33B |